Balanced cell proliferation and cell death determines neural precursor cell numbers in early stages of neural tube (NT) development. We have previously shown that nitric oxide (NO) regulates cell numbers locally in the NT of eight to 12 somite embryos. Here, we demonstrate that bone morphogenetic protein-4 (BMP-4), which is expressed in the ectoderm and dorsal NT at these developmental stages, induces programmed cell death (PCD) and promotes entry into the S-phase, via nitric oxide synthase (NOS) activity. These effects can be reversed by BMP-4 antagonists, such as follistatin and noggin, or by specific NOS inhibitors, resulting in low NO levels that facilitate mitosis and reduce PCD. Ectopic BMP-4 induction of PCD is restricted to the dorsal NT, whereas promotion of the S-phase is evenly observed across the dorsal-ventral (D-V) axis. Prolonged exposure to either BMP-4 or NOS inhibitors, which results in high or low NO levels, respectively, causes NT defects. The results presented here throw new light on the BMP signaling pathway. The local presence of BMP-4 helps to regulate cell numbers in the developing NT by a NO-mediated pathway, which is essential for normal NT formation.
Introduction
Cell numbers in multicellular organisms are determined by the balance between cell death and cell proliferation. However, the molecular mechanism of the spatiotemporal control of cell numbers remains poorly understood. The importance of programmed cell death (PCD) as a fundamental homeostatic mechanism during normal development is well established. 1 In many cases, a combination of PCD-activating andpreventing factors determines the survival and death of specific cells. [2] [3] [4] However, it is yet unclear as to how extracellular signals interact with intracellular signaling pathways to modulate the local balance between cell death and cell proliferation of most cell types. This important biological question should be addressed to allow an understanding of how organized tissues and organs form in the developing embryo.
Specific inhibitors of PCD block neural tube (NT) closure in explanted chicken embryos, suggesting that PCD is required for this crucial developmental process. 5 The obvious explanation for this phenotype was that blocking PCD at the time of NT closure affects cell numbers. We have recently reported that NO, a short-lived and short distance-acting mediator molecule, is endogenously produced in the neuroepithelium of eight to 12 somite chicken embryos, and plays a role in the regulation of cell cycle progression 6 and cell numbers in vivo.
7
High NO levels on the basal side promote entry into the Sphase, while low levels of NO facilitate entry into mitosis apically. 6 Moreover, PCD that normally occurs in the NT during these embryonic stages is blocked by the inhibition of endogenously produced NO, using nitric oxide synthase (NOS) inhibitors. 7 These findings prompted us to search for extracellular factors that modulate NOS activity in vivo, thereby controlling cell numbers in the NT.
Compelling evidence makes the extracellular factor, bone morphogenetic protein (BMP), which is expressed in the dorsal NT along the A-P axis at these embryonic stages, 8 an attractive candidate. BMPs constitute a subclass of the transforming growth factor-b superfamily of soluble proteins. Originally characterized by their osteogenetic activity, 9, 10 BMPs are expressed throughout embryogenesis, playing pivotal roles in mesoderm patterning and neural plate induction. [11] [12] [13] The vertebrate neural ectoderm undergoes a period of rapid proliferation and morphogenetic movements to form an NT. This involves signals originating from adjacent tissues that induce dorsal-ventral (D-V) and A-P identities on neural precursor cells.
14 Initially, BMPs are expressed at high levels in non-neural ectoderm and later also in the roof plate of the NT. 8, 15, 16 A BMP activity gradient across the D-V axis of the NT induces dorsal identity markers indicative of neural crest or dorsal interneuron precursors. [17] [18] [19] [20] BMPs also induce apoptosis in the early developing central nervous system (CNS), [16] [17] [18] [19] [20] [21] neuronal differentiation in mid-gestation of CNS precursors 22, 23 and glial differentiation in late embryonic or adult CNS precursors.
Here, we investigate the possibility that locally produced extracellular factors, such as BMP and its antagonists, are involved in the regulation of cell numbers in the NT either by driving cells into the cell cycle or by controlling PCD. Here, we show that BMP-4 induces PCD and promotes the entry of neuroepithelial cells into the S-phase in a concentrationdependent manner by increasing NOS activity. NOS inhibitors and BMP antagonists, such as follistatin and noggin, lower endogenous NO levels, reduce PCD and facilitate mitosis. This establishes a balance between cell proliferation and PCD. In addition, we demonstrate that adequate NO levels regulated by the BMP/NO pathway are required for normal NT formation. Prolonged exposure to high or low NO could be responsible for NT defects.
Results
Ectopic BMP-4 positionally regulates PCD and the S-phase across the D-V axis of the NT In the chicken embryo, during the time of NT closure and before the onset of neuronal differentiation, regulation of cell numbers in the NT depends mostly on the level of cell proliferation and PCD. 25 To explore the molecular mechanisms that locally regulate PCD and cell proliferation in early NT development, we studied the role of BMP-4 in cell number regulation at the time of NT closure. In light of the fact that BMP-4 induces apoptosis in the rhombencephalic neural crest of the chicken embryo, 26 we hypothesized that BMP-4 could be one of the extracellular factors responsible for the endogenous pattern of cell death. Such cell death had previously been observed along the A-P axis of the NT of the eight to 12 somite stage embryos at the time of NT closure. 5 To test this hypothesis, beads loaded with BMP-4 (113 mg/ml) were implanted in the lumen of the NT of eight to nine somite stage embryos, at the position of somite 5, and incubated in ovo for 6 h. To characterize the local effects of BMP-4 on cell death, the embryos were stained with neutral red to visualize the pattern of cell death around the bead. An increase in the number of cells stained with neutral red was observed around the BMP-4 beads (Figure 1a ), compared to the normal pattern of staining observed around the control beads (Figure 1b) . To verify that the neutral red staining by BMP-4 represents a bona fide PCD, we analyzed NT transverse sections around the bead, by double labeling with propidium iodide (PI) to determine nuclear morphology, and with CM1 antibodies, which cross react with the chick orthologue of caspase-3, and specifically identifies the active cleaved form. 27 Significant numbers of cells induced by BMP-4 to undergo PCD were found in the dorsal NT, as judged by localized caspase-3 activity (green) and by typical pyknosis of the nuclei (red) (Figure 1c and d) . These results suggest that within 6 h of local exposure to BMP-4, a caspase-3-like activity is induced in the dorsal half of the NT. To quantify the effect of BMP-4 on PCD, and cell cycle progression, we implanted into the NT beads loaded with decreasing concentrations of BMP-4 (113-0.113 mg/ml). Cells in the S-phase were identified by bromodeoxyuridine (BrdU) incorporation for the last 2 h of the experiment. Serial NT transverse sections around the beads were stained with PI and with anti-BrdU antibodies. The data presented in Figure 2 show that BMP-4 induced PCD significantly in a dose-dependent manner (Figure 2a ), had no effect on the proportion of cells undergoing mitosis (Figure 2b ), but increased substantially the number of cells entering the S-phase (Figure 2c ). Interestingly, BrdU-positive nuclei showed a normal D-V distribution in the NT (data not shown). These results suggest that the BMP signal is Figure 1 BMP-4-implanted bead locally induces PCD in the NT. BMP-4 or PBS (control) soaked beads (50-100 mm in size) were implanted in the NT at the level of somite four to five of eight to nine somite embryos in ovo and incubated at 381C for 6 h. Embryos that developed into 12 to 14 somites were taken for analysis. PCD was assessed qualitatively by neutral red staining in micrographs in 
BMP-4 induction of PCD and promotion of entry into the S-phase is mediated by NOS activity
Having shown the effects of BMP-4 on PCD and on cell cycle progression, we next tested whether there is a direct effect of BMP on NOS activity that was previously shown to be a modulator of PCD and cell cycle progression. 6, 7 BMP-4 beads (113 mg/ml) were implanted into the NT, as described above in the presence or absence of N G -methyl-L-arginine (L-NMMA), an L-arginine analogue that acts as an NOS inhibitor. NO production in the developing NT was monitored by using the cell-permeable fluorescent NO indicator 4,5-diaminofluorescein diacetate (DAF-2DA), applied on top of the embryos in ovo at the end of the 6 h incubation. Embryos were removed at the end of the incubation and analyzed under a confocal fluorescent microscope. Representative NT transverse sections of similar experiments described above were stained with PI to reveal pyknotic nuclei. While around the untreated control bead the few pyknotic nuclei were distributed at different D-V positions (arrows Figure 4a) , pyknosis was consistently observed in the dorsal NT around the BMP-4 bead (arrows Figure 4b) . The NOS inhibitor L-NMMA caused a significant reduction in the extent of pyknosis induced by BMP-4 ( Figure 4c ). To test whether the effect of BMP-4 on the promotion of the S-phase takes place via NOS activity, we applied BrdU for the last 2 h of the experiment. Representative NT transverse sections double labeled with PI and anti-BrdU show that the endogenous levels of BrdU incorporation in the untreated control sections (Figure 4d ) are much lower than in the BMP-4- Figure 2 Concentration-dependent effect of BMP-4 on PCD, mitosis and the Sphase. Beads were soaked in four different BMP-4 10-fold dilutions, starting at 113 mg/ml (1 : 1) diluted down to 0.113 mg/ml (1 : 1000). Beads were implanted in the NT between somites 4 and 5 of eight to nine somite stage embryos in ovo for 6 h. Transverse NT sections equivalent to 300 mm in length, around the bead area, were stained with PI to quantitate the proportion of PCD (a) and mitosis (b) from total nuclei identified by their characteristic nuclear morphologies (nuclear pyknosis and mitotic figures, respectively). The proportion of BrdU incorporation (c) was determined in NT transverse sections from three embryos double labeled with PI and anti-BrdU antibodies. The results are expressed as mean7S.D. An average of 4000 cells were scored per embryo. One-way ANOVA with post hoc test using Tukey B method found a significant difference between groups: in (a) 113 mg/ml BMP-4 is different from the rest and in (c) 113 and 1.13 mg/ml BMP-4 are similar and different from the rest Figure 4g shows the quantitative analysis of the effects of BMP-4 on mitosis and PCD in the NT. While ectopic BMP-4 increases the proportion of PCD, cotreatment with L-NMMA reverses the BMP-4 effect. In contrast, mitosis is not affected by BMP-4. The increase in mitosis and decrease in PCD by L-NMMA treatment is in accord with our previous observations that low NO levels produced by direct NOS inhibition facilitate mitosis 6 and inhibit PCD in the NT neuroepithelium. 7 A quantitative analysis of the BrdU incorporation experiments (Figure 4h ) shows that L-NNMA can lower the effect of BMP-4 on the number of cells that enter the S-phase to almost control levels. L-NMMA treatment alone does not affect the endogenous proportion of BrdU-positive cells (data not shown), as had been shown previously. 6, 7 These results taken together argue that ectopic BMP-4 induces PCD and promotes entry into the S-phase by increasing NOS activity in the developing NT. Notably, while the induction of PCD is restricted to the dorsal half of the NT, the effect on cell cycle progression is evenly distributed across the D-V axis of the NT.
Next, we performed experiments to test the impact of the BMP/NO effects (particularly on PCD) on normal NT formation in 24 h treated embryos as seen in Figure 4i -k (see online supplementary material). Interestingly, under these experimental conditions, BMP-4-loaded beads (producing high NO levels) and L-NMMA treatment (low NO levels) inflicted NT defects. Yet, normal NT morphology was observed when both treatments were combined. Interestingly, the prolonged BMP-4-mediated induction of PCD in the dorsal NT caused massive cell loss that can result in an open NT by the elimination at the midline of the roof plate forerunner. These results demonstrate the importance of cell number control by BMP/NO and the requirement of adequate NO levels for normal NT development. 
BMP antagonists reduce endogenous NO levels required for entry into mitosis
It is shown above that BMP signaling exerts its activity in the NT neuroepithelium in a concentration-dependent manner via NOS activity. At high BMP-4 concentrations, the higher NO levels produced increase PCD and promote entry of cells into the S-phase, with no effect on the level of mitosis. Therefore, BMP signaling must be strictly downregulated to lower NO levels that will allow an adequate number of cells to cycle in the neuroepithelium toward mitosis. 6, 7 To further elucidate the mechanism by which BMP-4 affects cell numbers by regulating NO levels in the NT, we used the BMP antagonists follistatin 15, 28 and noggin 29 to try to neutralize the effects of ectopic BMP-4. BMP-4-loaded beads (113 mg/ml) were implanted in ovo into the NT of eight to nine somite embryos at somite 5, and either 0.5 mg/ml follistatin or 0.8 mg/ml noggin were applied on top of the embryos, which were incubated for 6 h. In parallel, 0.5 mg/ml follistatin or 0.8 mg/ml noggin were loaded onto beads and implanted into the NT to test their effects on endogenous BMP and cell numbers in the NT. Figure 5a summarizes a quantitative analysis of the proportion of cells undergoing mitosis, PCD and BrdU incorporation. Data were collected from NT transverse sections around the beads and double labeled with PI and anti-BrdU. The results show that, while follistatin and noggin increase mitosis in the presence or absence of BMP-4, they completely abolished the BMP-4 effect on PCD and significantly reduced the effect of BMP-4 on entry of the cells into the S-phase. These results suggest that follistatin and noggin can serve as regulators of BMP-4 activity in the NT. This adds significantly to our understanding of the molecular mechanism involved in cell number control in the developing NT.
To determine whether this pathway of BMP signal antagonism leads to the control of NOS activity, we tested the capability of BMP antagonists to lower endogenous NOS activity. NOS activity assays were carried out with extracts made of NT and somites dissected from embryos, which were cultured for 6 h in the presence of 50 mg/ml follistatin, 11 mg/ml noggin or 10 mM L-NMMA. NOS .These values are averages of three independent experiments that were performed with extracts prepared from dissected NTs of a pool of 12 embryos per treatment. These results suggest that by antagonizing endogenous BMP, both follistatin and noggin reduce endogenous NO levels in the developing NT of the chicken embryos.
We have previously shown that high NO levels produced by the NO donor S-nitroso-N-acetyl-penicillamine (SNAP) promoted entry of cells into the S-phase, while the NOS inhibitor L-NMMA facilitated mitosis. 6 Treatment with a combination of SNAP and L-NMMA resulted in unchanged mitosis. Similarly, the results shown in Figure 5b demonstrate that a combination of SNAP and follistatin reverses the follistatin-dependent effect on mitosis and PCD. These results further support our proposal that NO is a downstream mediator of a BMP-4 pathway; thus low NO levels are needed to facilitate mitosis.
We reasoned that the antagonistic activities of BMP-4 and follistatin may play a role in the promotion of cells to enter mitosis. Based on the fact that as little as 2 h are required for BrdU-positive nuclei to reach mitosis in an L-NMMA-treated neuroepithelium, while at least 5 h are required in untreated controls and SNAP-treated embryos (data not shown), we designed the following experiment. BMP-4 beads were implanted into the NT of eight to 10 somite embryos and incubated for 6 h. BrdU was added 2.5 h after the onset of the incubation, which was followed by the addition of follistatin on top of the embryos 30 min later. We tested the possibility that BrdU-labeled nuclei can be driven into mitosis by follistatin during the remaining 3 h of incubation. Confocal micrographs (shown in Figure 5c ) were taken from the bead area in NT transverse sections double labeled with PI (red) and anti-BrdU (green). The images were taken from untreated control embryos and embryos treated with BMP-4, follistatin or BMP-4 plus follistatin. Yellow-stained nuclei testify for colocalization of both BrdU and PI labels. Notably, doublelabeled PI/BrdU-positive mitotic nuclei appeared at the end of the incubation period only in the ventricular zone of the NT in embryos treated with follistatin plus BMP-4 or follistatin alone (see arrows). These results suggest that follistatin antagonizes BMP-4 activity, thereby lowering NO levels. The low NO levels allow BrdU-positive nuclei to progress toward mitosis within 3 h.
Discussion
During early NT development, endogenous NO regulates cell cycle progression 6 and cell numbers. 7 Yet, the extracellular factors involved in the regulation of NO levels in the NT were not identified. In the present study, we report that BMP-4 induces NOS activity in the neuroepithelium of eight to 12 somite chicken embryos. Figure 6 presents a scheme of a proposed mechanism by which BMP-4 affects NT cell cycle progression and PCD in an NOS-mediated manner. The balance between BMP-4 (red) and its antagonists such as follistatin and noggin (blue) locally modulates NOS activity in the neuroepithelium. As a result, levels of NO change and consequently PCD levels and cell cycle progression are affected. When BMP is released from the effects of its antagonists, due to high local concentration, cells undergo PCD via NOS in the dorsal NT where BMP-4 is endogenously expressed. 8 Remarkably, in this scenario, the BMP/NOS pathway apparently induces Wnt signaling. In preliminary studies in embryos treated with the BMP antagonist follistatin or NOS inhibitor L-NMMA that reduce NO levels, we observed a reduction in b-catenin expression (data not shown), suggesting a decrease in Wnt signaling. This is in accord with previously reported findings that dorsal medial Wnt signaling is responsible for equal entry of neural precursor cells into the S-phase dorsoventrally at this early developmental stage in the NT by inducing in a similar manner the expression of late G1 cyclins D1 and D2. 25 The low NO levels ( Figure 5 ) and presumably the reduction of Wnt signaling may promote mitosis by allowing the transcription of relevant G2/M cyclins enabling cell cycle progression ( Figure 6 ). This assumption is in accord with the observation carried out by Megason and McMahon 25 that dominant active b-catenin upregulates in the developing spinal cord the expression of cyclin D1 and cyclin D2 but not the G2/M cyclins A1 and B3.
Moreover, the Wnt proliferative activity that we and others observed across the D-V axis in early NT development changes later with the increase in NT size at later stages. This limits Wnt proliferative activity dorsally and induces neural differentiation ventrally. 25 This may explain how the BMP-4 / NO pathway may affect cell cycle progression evenly across the D-V axis at this time in NT development. It could also Figure 5 BMP regulation of cell numbers requires a BMP antagonist to modulate NO levels to promote cell cycle progression. (a) Quantitative analysis of the proportion of mitosis, PCD and BrdU incorporation in embryos treated with the control, BMP-4 (113 mg/ml), follistatin (500 mg/ml) or noggin (800 mg/ml) beads and BMP-4 beads with follistatin or noggin (in 20% pluronic gel) for 6 h. NT sections around the beads were double stained by PI and anti-BrdU antibodies and analyzed as explained in Figure 2 . The results are expressed as the mean7S.D. calculated from n ¼ 4 embryos under each condition. An average of 4000 nuclei were scored per embryo. The significance of the treatment effect was estimated by two-way ANOVA on % of mitosis: for follistatin, Po0.001; for noggin, Po0.001, on % of PCD and on % of BrdU positive: for all treatments Po0.007. (b) Follistatin effects on PCD and mitosis are reverted by NO donor SNAP. Quantitative analysis of the proportion of mitosis and PCD on PI-stained NT sections of embryos treated with 500 mg/ml follistatin or control beads in the presence or absence of 2.5 mM SNAP for 6 h. The results are expressed as the mean7S.D. calculated from n ¼ 6 embryos under each condition. An average of 4000 nuclei were scored per embryo. The significance of the treatment effect was estimated by two-way ANOVA on % of PCD: for SNAP P ¼ 0.02, on % of mitosis: for follistatin, for SNAP and for follistatin-positive SNAP Po0.001. (c) BMP-4 or control beads (113 mg/ml) were implanted in the NT of eight to nine somite embryos and incubated for 6 h. BrdU was applied after 2 h of incubation and 500 mg/ml follistatin (in 20% pluronic gel) treatment was added on top of the embryos 30 min later for the remaining incubation period. Confocal micrographs of NT transverse sections double labeled by PI (red) and by BrdU immunofluorescence (green), taken near the bead, of an untreated control, BMP-4-treated, BMP-4 plus follistatin or follistatin-treated embryos. The lower left panel of each treatment shows the respective DIC transmission image of the NT section. The merged red and green confocal images resulting in pixel colocalization, where double labeled nuclei become yellow. Confocal analysis of multiple sections from all four treatments revealed that no BrdU-labeled nuclei were visibly engaged in mitosis in untreated or BMP-4-treated embryos by the end of the 6 h incubation. Size bar 20 mm explain why at later developmental stages when the spinal cord increases in size, the role of BMP in dorsal neural pattern formation is different, being more restricted dorsally. [17] [18] [19] [20] The BMP/NO mediation of the Wnt signaling in NT formation requires further characterization.
The concentration-dependent experiments described here show that high BMP-4 concentrations induce PCD and promote the S-phase. Interestingly, a low BMP-4 concentration (1.13 mg/ml) still promotes the S-phase but cannot induce PCD (Figure 2 ). These effects of BMP-4 on S-phase promotion are across the D-V axis of the NT (Figure 4d-f) , while ectopic BMP-4 induces PCD only in the dorsal half of the NT (see Figures 1c and 4a-c) . This unexpected result suggests that local BMP-4 concentrations along the D-V axis elicit accordingly different signaling pathways that induce caspase-mediated PCD in the dorsal part of the NT on the one hand (Figures 1c and d) , and a different pathway that promotes entry into the S-phase across the D-V axis on the other, yet both BMP-4 pathways are mediated by NO. Taken together, the BMP-4/NOS pathways are responsible for two different cell fates that are positionally determined dorsoventrally, in the developing NT of the chick embryo according to BMP availability. Our experiments described in Figure 4i -k (on line supplemental data) suggest that prolonged exposure to BMP-4 or L-NMMA (24 h) could lead to NT defects, with different morphological features. BMP-4 (high NO levels)-induced dorsal PCD, as shown previously for 12 h SNAP treatment, 7 can cause reopening of the NT inflicted by the progressive elimination of neural precursor cells through PCD at the dorsal midline of the NT. On the other hand, low NO levels produced by L-NMMA cause significant dorsoventral morphological defects that include an increase of PCD and abnormal thickening and closure of the NT. Evidently, BMP-4 overexpression (high NO) and low NO levels produced by L-NMMA exert different effects on the neural precursor cell population with deleterious consequences on NT formation. The different effects observed with different NO levels are eliminated when both treatments are combined, resulting in normal NT morphology. This suggests that adequate NO levels produced by BMP-4 are required for normal NT formation. This conclusion is strengthened by the fact that in noggin null mice, excessive cell death and NT closure defects is observed at the dorsal NT midline presumably as a consequence of increased BMP activity. 30 Further support to this conclusion comes from the premature activation of the BMP-4 target gene Msx-1 in the dorsal NT, which in turn has been implicated in BMP-4-induced apoptosis.
16,26 BMP signaling activates Smad 1/5/8 proteins, which associate with Smad 4 before translocating to the nucleus. The endogenous pattern of activated Smad1/5/8 was recently observed in the 11 somite embryo, across the entire dorsal midline of the NT. 31 Taking these and our observations together, it may be suggested that BMP-4 induces PCD via a Smad 1/5/8 signal in the dorsal midline of the NT. However, this pattern of activated Smad 1/5/8 cannot explain why BMP-4 transducing signal involved in cell cycle regulation is evenly distributed across the D-V axis of the NT. This suggests that there must be another intracellular BMP signal transduction pathway operating via NO involved in promoting cell cycle. Our observation that Wnt signal operates via the BMP/NO pathway strongly supports this possibility. Having observed two different positional BMP-4 effects, we suggest that two BMP-4 transduction pathways exist. This suggestion is supported by several lines of previously published observations. First, the pattern of expression of bmpr-1a and bmpr-1b in the CNS of mouse embryos suggests that they have distinct roles in the transduction of BMP signal. 32, 33 Second, while BMPR-IA is expressed ubiquitously in the NT and promotes BrdU incorporation into the CNS precursor cells, BMPR-IB is restricted to the dorsal NT where BMP is produced. In the dorsal NT, BMP limits precursor cell numbers by causing mitotic arrest, and consequently apoptosis in early gestation and terminal differentiation at mid-gestation embryos. 34 Here, we establish the impact of high BMP-4 concentrations on neural cells in the dorsal NT in prolonged 24 h incubations. How the BMP-4/NO pathway is involved in dorsal neural fate patterning of the spinal cord at later developmental stages remains to be investigated.
The ability of BMP-4 to promote entry into the S-phase via NOS induction without concomitantly increasing mitosis, as described here, sheds light on our previous findings that neuroepithelial cells require high NO levels to enter the Sphase, and low NO levels to facilitate mitosis. 6 It appears that BMP-4 has no direct mitogenic effect on neuroepithelial cells. The effect on mitosis is only observed in the presence of its antagonists follistatin or noggin that lower NO levels (see Figure 5 ). This effect is restored to normal levels in the presence of the NO donor SNAP. It can therefore be concluded that the availability of the BMP-4 signal, which is Figure 6 Locally available BMP modulates NO concentration, thus regulating cell numbers in the developing NT. BMP-4 as an extracellular growth factor, transduced via a specific cell membrane receptor, activates intracellularly NOS (red route). Increase in NO concentration facilitates the entry of basally positioned cells into the S-phase. This requires nuclei to be basally positioned presumably by activating the canonical Wnt signaling pathway that blocks bcatenin proteosomal degradation. We have observed an increase in b-catenin levels in embryo extracts (data not shown). A local BMP-4 antagonist, such as follistatin or noggin, lowers effective BMP levels in the extracellular space (blue route), reduces NOS activity and concomitantly NO levels that presumably result in reduced Wnt signaling (decrease in b-catenin levels). Low levels of NO facilitate the entry into the M-phase of cells in which nuclei are positioned apically. These effects on the S-phase and mitosis are evenly distributed across the D-V axis. Remarkably, higher concentrations of BMP-4 are probably required to induce high production of NO. This triggers positional apoptosis in the dorsal NT, which can be blocked by the BMP-4 antagonists that lower the NO levels dependent on its antagonists activity, controls cell numbers via the production of adequate NO levels in the NT that is required for normal NT formation (see Figure 4i -k and respective online supplementary data).
Materials and Methods
Experimental manipulations on chicken embryos in ovo Fertilized White Leghorn chicken eggs were incubated at 381C for 35-38 h and staged in ovo according to Hamburger and Hamilton (HH). 35 Experiments were performed in ovo on embryos at eight to 10 somite stage (HH 9). BMP-4 at 113 mg/ml and at lower concentrations (Wyeth Research, MA, USA) or 0.5 mg/ml follistatin (National Hormone and Pituitary Program, CA, USA), as well as 0.8 mg/ml noggin (condition medium from noggin overexpressing cells (see below)) were applied to 50-100 mm heparin acrylic beads (Sigma). Proteins were loaded onto beads as described. 36 Control beads (soaked in PBS) and protein-loaded beads were implanted in the NT simultaneously, at the level of somite 4. For NOS inhibition, embryos with implanted, BMP-4 beads or control beads, were treated with 50 mM L-arginine analogue L-NMMA (Sigma). To increase NO levels, the NO donor SNAP (Sigma) was added at 2.5 mM concentration on top of follistatin and control bead-implanted embryos. The chemicals were applied in 2 ml pluronic gel solution (20% w/v) that solidifies on top of the embryo. Eggs were then sealed and incubated at 381C for 6 h. At the end of the incubation, all embryos were staged under a dissecting microscope and those that developed to the 11 to 14 somite stage were fixed in 4% paraformaldehyde and processed for cryosectioning as described previously. 5 In 24 h incubation experiments, BMP-4 and control beads were implanted in eight to 10 somite embryos at two sites in the NT along the A-P axis, the anterior bead at the level of somite 4 and the posterior one caudal to the newly formed posterior somite. Treatments with 50 mML-NMMA or PBS were applied every 4 h for the first 12 h of the incubation period followed by a last application 6 h later. Embryos were staged and processed for qualitative analysis of cell death and NT morphology, as explained below.
Collection of noggin-conditioned medium
To obtain noggin in high concentration for bead implantation experiments, 10 mg of pcNoggin cDNA plasmid (a gift from Richard Harland's laboratory), encoding the full-length xenopus Noggin homolog 37 or control pcDNA-1 plasmid vector, was transfected using calcium phosphate method into HEK 293T cells cultured in three 9 mm dishes with Dulbecco's modified Eagle's medium (DMEM) containing glucose, Glutamax-1 and sodium pyruvate supplemented with 10% fetal bovine serum and penicillin-streptomycin (Gibco). pEGFP cDNA plasmid (0.25 mg) (Clontech) was cotransfected as a reporter of gene expression. Green fluorescence protein expression was verified under a fluorescent inverted microscope 48 h after transfection. Then, noggin expressing and transfected control cells were washed and cultured in DMEM without serum. The conditioned media with or without noggin were collected from the plates for 2 consecutive days and the total volume was concentrated down to 150 ml and dialyzed simultaneously in a vivaspin 20 (cutoff MW 10 000 kDa) (Vivascience, Sartorius AG, Germany) by centrifugation at 1500 Â g at 41C using a bench top centrifuge. The protein contents of the two conditioned mediums were determined by colorimetry using the BioRad protein assay following the manufacturer's instructions (Bio-Rad laboratories, Gmbh). About 100-fold more protein was present in a nogginconditioned medium compared to the control.
Neutral red staining of whole embryos
After 6 or 24 h incubation, embryos were stained for 5 min with a 5 ml drop of 100 mg/ml neutral red applied on top of the embryo, then removed with their membranes from the eggs, washed in PBS and immediately placed flat, ventral side down in a 35 mm dish filled with 1% agarose. Neutral red staining was visualized under an Olympus SZX9 dissecting microscope with bright field illumination and the embryos were photographed using an attached Nikon coolpix 950 digital camera. Digital images were arranged for comparative analysis with Adobe Photoshop 4.0.
Quantitative analysis of apoptosis and mitosis on PI-stained NT sections Treated embryos were removed from the eggs and fixed in 4% PFA/PBS and processed for frozen sectioning into coated gelatin slides as described before. 5 To quantitate the proportion of mitotic and apoptotic cells in the NT around the implanted bead, at least 30 serial transverse sections, 10 mm thick, were stained with 1 mg/ml PI to visualize the nuclei, as described previously. 5 The stained section images were recorded under a Till-Photonics image system attached to an Olympus BX52 fluorescent microscope and stored as 8 bit TIFF files. The images were arranged with Adobe Photoshop 4.0 for quantitative analysis on 1440 dpi in A4 size highquality prints, using Epson Stylus 850 printer.
Immunofluorescence and BrdU incorporation
Immunodetection of activated caspase-3 in the cytoplasm of apoptotic cells in NT transverse sections of the chick embryo was performed using CM1 affinity purified antibodies (BD-Pharmingen, CA, USA) and double labeled with PI to visualize pyknosis as described previously. 27 For BrdU incorporation analysis, a drop of 3.5 ml of 40 mM BrdU was added on top of the embryos in ovo for the final 2 h of the incubation period or otherwise stated in specific experiments. The embryos were then fixed in cold 4% PFA/PBS and prepared for cryosectioning. Transverse sections of the NT around the implanted beads were taken for analysis as explained above. The sections were permeabilized in cold methanol for 10 min, rinsed with PBS and then treated with 2 N HCl for 40 min at 371C. The sections were neutralized in 0.1 M sodium tetraborate pH 7.4 for 10 min and rinsed in PBS. Sections were then stained with BU-33 mouse monoclonal anti-Brdu antibody (Sigma) followed by fluorescein-coupled goat anti-mouse immunoglobulin antibodies (Jackson IR) both for 1 h at room temperature. The sections were finally labeled with PI, mounted and examined under a Till-Photonics image system attached to an Olympus BX52 fluorescent microscope as described above.
In situ localization of NO in NT in whole-mount embryos using DAF2-DA Intracellular localization of NO in NT cells of whole-mount embryos was examined using the cell permeable fluorescent NO indicator DAF-2DA (Alexis biochemicals), which is detected by an excitation wavelength of 495 nm and an emission of 515 nm under a Zeiss LSM 510 confocal laserscanning microscope. Chick embryos with implanted control beads (PBS) and BMP-4 beads in their NT were treated with or without 50 mM L-NMMA in ovo as explained above. A 3 ml drop of 250 mM DAF-2DA diluted in PBS was applied on top of the embryos 20 min before the end of the 6 h incubation period. The embryos were removed from the egg and membranes rinsed in PBS and mounted inside a silicone grease made well on top of a glass microscope slide filled with PBS and covered with a microscope coverslip to build a sealed microchamber. The scan was performed under a 40 Â 1.2 NA water objective to obtain a 141 mm thick optical section z-series 512 Â 512 pixels images. A 3D projection image was built from the sum of these images using Zeiss LSM software. Each frame of the 3601 rotation, JPG images were assembled to produce a moving image using i movie software program for Macintosh.
Detection of NOS activity in chick embryos
Embryos at the eight to 12 somite stage were removed from the eggs and their membranes and pooled into groups of seven to 10 embryos in a culture dish with 250 ml DMEM, with or without 50 mg/ml follistatin or 10 mM L-NMMA, and incubated at 371C with 5% CO 2 . L-Arginine [H 3 ] (10 mCi) (Amersham, UK) was applied in the last 4 h of incubation time. Labeled embryos were rinsed in cold 1 mM EDTA-PBS and embryo homogenates were prepared in 10 ml/embryo homogenization buffer (25 mM Tris-HCl (pH 7.4), 1 mM EDTA, 1 mM EGTA). The homogenate was centrifuged at 41C for 30 min at 14 000 rpm. NOS activity was measured using NOS detect kit (Stratagene) according to the manufacturer's instructions. Protein contents of the supernatant were determined by colorimetry using the Bio-Rad protein assay following the manufacturer's instructions (Bio-Rad laboratories, Gmbh).
Statistical analysis
The significance of each treatment alone or combination of two treatments was examined by two-way analysis of variance (ANOVA) after transformation of arc.sin. sq.root of the proportion of mitosis, PCD or BrdU positive to reach a normal distribution. In concentration-dependent experiments with one treatment, significance was examined using oneway ANOVA. When significant differences were indicated in the F ratio test (Po0.001), the significance of differences between means of any of these groups was determined using the modified Tukey B method for multiple comparisons, with a ¼ 0.05.
